Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain

NCT05086289 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Low-back Pain

Interventions

DRUG: LY3526318
DRUG: Placebo

Sponsor

Eli Lilly and Company